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In Brief
Transport of antigen to the stromal
follicular dendritic cell (FDC) population is
important for antibody production.
Heesters and Carroll show that, in
addition to B cells, dendritic cells also
have the capability to transport antigen to
FDCs. Furthermore, they show that intact
bacteria (S. pneumoniae) are transported
to FDCs.
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Affinity-mature B cells require cognate antigen, re-
tained by follicular dendritic cells (FDCs), for clonal
selection within germinal centers. Studies on how
FDCs in lymphoid tissues acquire antigen have relied
primarily on model protein antigens. To examine de-
livery of intact bacteria to FDCs, we used inactivated
Streptococcus pneumonia (SP). We found that both
medullary macrophages and a subset of SIGN-R1-
positive dendritic cells (DCs) in the lymph node cap-
ture SP from the draining afferent lymphatics. The
presence of DCs is required for initial complement
activation, opsonization of the bacteria, and efficient
transport of SP to FDCs. Moreover, we observed a
major role for transport of bacteria to FDCs by naive
B cells via a CD21-dependent pathway. We propose
a mechanism by which efficient transport of SP to
FDCs is dependent on DCs for initial binding and
activation of complement and either direct transport
to FDCs or transfer to naive B cells.INTRODUCTION
The Gram-positive pathogen Streptococcus pneumoniae (SP),
commonly known as pneumococcus, is the predominant cause
of community-acquired pneumonia and causes many cases
of Otis media, sinusitis, meningitis, and septicemia (Musher,
1994; Tomasz, 2000; Tuomanen, 2004). SP resides in the naso-
pharynx as a commensal in up to 20%of healthy adults and up to
50% of healthy children. It is an opportunistic bacterium and
infection often occurs after another respiratory tract infection,
e.g., during influenza pandemics the leading cause of death is
often a secondary infection with SP (Palese, 2004). Invasive
pneumococcal disease leads to high mortality and morbidity
rates, especially in young, elderly, debilitated, or immunosup-
pressed individuals (Janoff and Rubins, 1997). Worldwide more
than one million people die from pneumococcal infections
each year, mostly in the developing world (Klein et al., 1994; Mul-
holland, 1999). However, the rate at which resistance of SP to
antibiotics is increasing in the United States and the rest of the
developed world is alarming (Appelbaum, 2002; Klugman,3130 Cell Reports 16, 3130–3137, September 20, 2016 ª 2016 The A
This is an open access article under the CC BY-NC-ND license (http://2004). As of 2013, data show that SP is resistant to one or
more antibiotics in 30% of clinical cases (Centers for Disease
Control and Prevention, 2013a, 2013b).
Clearance of SP is mediated through opsonization by immu-
noglobulin (Ig) and complement. In 1969 it was shown that com-
plement is protective in pneumococcal disease by increasing
phagocytosis (Johnston et al., 1969). Opsonization of SP with
complement C3 and its breakdown product C3d facilitates up-
take of immune complexes (ICs) by CD21 (Griffioen et al.,
1991). Recognition and binding of SP by the C-type lectin recep-
tor SIGN-R1 activates the classical complement pathway via
C1q, leading to opsonization and deposition on the follicular
dendritic cell (FDC), which is required for humoral immunity
against SP (Brown et al., 2002; Kang et al., 2006).
Despite these elegant findings on the mechanism of antigen
binding and complement activation, it remains unclear how SP
is delivered to B cell follicles in draining lymph nodes (LNs) for
presentation in germinal centers (GCs). Earlier studies tracking
uptake of particulate antigen within skin-draining LNs show
that subcapsular sinus macrophages (SCSMs) were essential
in the induction of a humoral response and have been referred
to as guardians of the LN (Gaya et al., 2015). In similar studies,
Cyster and colleagues identified one pathway by which SCSMs
bind C3-opsonized IC via complement receptor 3 (CR3) and
shuttle it into the underlying B cell compartment, where mature,
non-cognate B cells take up the opsonized IC via CD21 (Phan
et al., 2007, 2009). More recently, Heesters et al. (2013) reported
that naive B cells deliver C3-opsonized IC directly to FDCs,
where it is transferred via CD21 and rapidly internalized into a
cycling endosomal compartment for long-term retention.
FDCs play a critical role in regulating the architecture of B cell
follicles and maintenance of GCs via secretion of chemokines
and cytokines and retention of antigen (Tew et al., 1990; Wang
et al., 2011; Wu et al., 2009). Studies using model protein anti-
gens demonstrate that B cell activation in the presence of co-
stimulation by T follicular helper (TFH) cells leads to the formation
of GCs, where B cells undergo class switch recombination and
somatic hypermutation, which finally results in differentiation to
memory and effector B cells (see Victora et al., 2010 for review)
(Victora andNussenzweig, 2012). FDC retention of antigen within
GCs is required for efficient clonal selection and affinity matura-
tion as cognate B cells acquire antigen and present it to TFH
cells (Gitlin et al., 2015; Shulman et al., 2013; Suzuki et al.,
2009; Victora et al., 2010).uthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Capture of Streptococcus pneu-
monia Is Exclusive to the Medulla
(A) Left: confocal image of the popliteal lymph node
(pLN) in a mouse immunized with Streptococcus
pneumoniae (SP) (CMTPX, red) 2 hr prior. Sub-
capsular sinus (SCS) macrophages (MOMA-1,
green) mark the SCS area, while medullary mac-
rophages (MMs) (F4/80, blue) mark the medullary
region. Scale bar, 100 mm. Right: magnification of
the transition from medulla to SCS in which single
cocci can be resolved. Gray scale image of the SP
channel shows selective binding to the medulla.
Scale bar, 10 mm.
(B) Quantification of (A) based on mean fluores-
cence intensity (MFI) of SP. Arrival and accumula-
tion of SP in the medulla is gradual over the course
of 12 hr. At 2 hr SP was detected in the medulla, in
contrast to the SCS region were no binding was
detected up to 24 hr (***p < 0.001, ANOVA with
Tukey’s multiple comparisons test).
(C) Confocal micrograph of the medulla-SCS
interface shows exclusive staining for SIGN-R1
(SR1, red) in the medulla. SCS is marked with
MOMA-1 (green). Grayscale image of the SR1
channel is shown. Scale bar, 10 mm.
(D) Quantification of (C) percentage of total identified cocci is shown (***p < 0.001, ANOVA with Tukey’s multiple comparisons test).
(E) Left: electron micrograph of an MM that has engulfed multiple SP (arrows), adjacent to the medullary sinus, is shown. Scale bar, 2 mm. Right: color-coded
overlay is shown to aid in structure identification.To track delivery of SP to the FDCs and its subsequent acqui-
sition by cognate B cells, we developed a model in which mice
were immunized subcutaneous (s.q.) with fluorescently labeled
inactivated SP. We found, unexpectedly, that SCSMs did not
bind SP and thatmacrophageswere not required for humoral im-
munity to SP. Instead, bacteria captured and opsonized by LN-
resident dendritic cells (LNDCs) were either handed off to naive B
cells in the nearby follicles or, although less common, trans-
ported directly to the FDCs. We propose a mechanism in which
B cells require dendritic cell (DC)-mediated opsonization of SP
(presumably through SIGN-R1) and in which both B cells and
DCs have the capacity to transport opsonized SP to the FDCs
within the LN follicles.
RESULTS
Medullary Macrophages Capture Lymph-Borne SP
To identify the mechanism underlying the capture and transport
of lymph-borne SP in the LN, mice were injected in the footpad
with fluorescent-labeled, heat-inactivated SP (strain D39, sero-
type 2). This results in passive drainage of the bacteria to the
popliteal LN (pLN) (Gonzalez et al., 2011; Roozendaal et al.,
2009). Imaging of cryosections of pLNs early after injection indi-
cates localization of SP in the medullary region and not in the
subcapsular region (Figure 1A). Capture is apparent at 2 hr after
injection, and quantification of the data shows an increase in
binding in the medullary region at 12 hr but negligible binding
in the subcapsular region over a 24-hr period (Figure 1B). This
was unexpected as earlier studies had identified the SCSMs as
required for humoral immunity to particulate antigens (Carrasco
and Batista, 2007; Gaya et al., 2015; Iannacone et al., 2010; Junt
et al., 2007). One difference from the earlier studies is that herewe immunized with intact bacteria. For example, influenza virus,
which is taken up by SCSMs, is opsonized by serum comple-
ment component mannan-binding lectin (MBL) whereas SP is
not (Figure S1A).
Medullary macrophages (MMs), which mark the medullary re-
gion, are distinguished by staining with antibody to SIGN-R1,
whereas SCSMs are identified with anti-MOMA-1 and a lack of
SIGN-R1 staining (Gonzalez et al., 2010; Phan et al., 2007). To
further identify cell types involved in the uptake of labeled SP,
cryosections of pLN isolated at 2 and 12 hr post-injection in
the footpad were stained with antibody to SIGN-R1 and
MOMA-1. Quantitation of the results identified a high percentage
of the SP co-localized with SIGN-R1+ MMs, whereas negligible
co-localization was observed with the MOMA-1+, SIGN-R1
SCSMs (Figures 1C and 1D).
Qualitative analysis of pLNs by electron microscopy (EM)
following injection of SP further confirmed internalization of the
bacteria by macrophages within the medullary, but not the sub-
capsular, region (Figure 1E). At later time points, SP was
observed in the follicular region, co-localizing with the FDC
marker 8C12; this is discussed in more detail below.
LNDCs and Macrophages Bind SP
Flow cytometric analysis of single-cell suspensions prepared
from pLN was performed to determine which cell types are
responsible for the binding and possible transport of SP to the
FDCs. Heat-inactivated fluorescent-labeled SP was injected in
the footpad and the pLN was harvested at 2 hr, after which a sin-
gle-cell suspension was prepared that was stained with anti-
bodies for CD11b, CD11c, CD4, CD8, and SIGN-R1. Three
distinct populations of CD11c+ DCs were identified as SIGN-
R1+ (i.e., CD11b-int SIGN-R1-int, CD11b-hi SIGN-R1-int, andCell Reports 16, 3130–3137, September 20, 2016 3131
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Figure 2. SIGN-R1+ Dendritic Cells and Macrophages Bind SP
All experiments were performed 12 hr after injection of fluorescently labeled
heat-inactivated SP in the footpad.
(A) Left: flow cytometry gating strategy to distinguish dendritic cells (DCs) and
macrophages. Right: based on SIGN-R1(SR1) and CD11b expression, three
DC subsets were identified.
(B) In the three groups defined, the MFI of SP was determined as a correlate of
binding (**p < 0.01 and *p < 0.05, ANOVA with Tukey’s multiple comparisons
test).
(C) Macrophages, plasmacytoid DCs, CD4+ DCs, and CD8+ DCswere divided
into SR1-positive (green) and -negative (blue and red) groups (negative group
comprised of both CD11bhi and CD11bint, SR1int groups), and the percentage
of total SP bound by these groups was determined (***p < 0.001; ns, not sig-
nificant; ANOVA with Tukey’s multiple comparisons test).
(D) Snapshot was taken from multiphoton intravital imaging of the pLN in a
CD11c-eYFP (green) mouse immunized with SP (red, white arrows) near the
medullary border. Scale bar, 10 mm.
(E) High-magnification image of an isolated B cell binding complement C3d-
coated SP on its surface. Structures are marked as follows: CD45R/B220,
blue; SP, red; and C3d, green. Scale bar, 5 mm.
3132 Cell Reports 16, 3130–3137, September 20, 2016CD11b-hi SIGN-R1-hi) (Figure 2A). Among the three populations,
CD11b-hi SIGN-R1-hi bound SP with the highest mean fluores-
cence intensity (MFI) (Figure 2B). Further analysis of this SP+
population revealed a specificity for SIGN-R1+ macrophages
and SIGN-R1+ CD4+ DCs (Figure 2C). One explanation is opso-
nization and subsequent stabilization through complement re-
ceptors CD11b andCD11c, also known as complement receptor
(CR) 3 and 4, respectively. The critical role of SIGN-R1 and com-
plement in SP opsonization and subsequent binding by DCs was
further emphasized by the lack of stable SP binding by DCs in
C3/ and C1q/ mice (Figure S1B). Opsonization through
SIGN-R1 ismediated by C1q (Kang et al., 2006). These data sug-
gest that stable binding of SP by DCs requires complement op-
sonization and possibly subsequent binding of either CR3 or
CR4 (CD11b or CD11c).
To follow the capture in the LN of SP by CD11c+ DCs in real
time, mice expressing enhanced yellow fluorescent protein
(eYFP) under the CD11c promoter were immunized with labeled,
inactivated SP, and uptake was visualized by multiphoton intra-
vital imaging (MP-IVM) of the pLN at 2 hr post-injection (Gonzalez
et al., 2010; Lindquist et al., 2004) (Figure 2D). Imaging of the in-
terfollicular region adjacent to the B cell follicles identified eYFP+
DCs in close proximity of the medullary sinus and loaded with
bacteria. DCs captured bacteria in close proximity to the medul-
lary sinus, possibly via SIGN-R1 (Figure 2D). Notably, a similar
uptake location and involvement of SIGN-R1+ LNDCs were re-
ported earlier by Gonzalez et al. (2010) following footpad injec-
tion of inactivated influenza A (IAV) viral particles. Interestingly,
complement C3-coated, labeled SP also was observed on the
surface of B220+ cells (B cells) (Figures 2E and S2A–S2D).
LNDCs Are Required for Immune Response against SP
To assess whether DCs, macrophages, or both are required for
an immune response against SP, chimeric mice were con-
structed in which bone marrow (BM) from CD11c-diphtheria
toxin receptor (DTR) transgenic mice was transferred into lethally
irradiated wild-type (WT) C57BL/6 recipients. In this model, BM-
derived cells within the CD11c-DTR>>WT chimeric mice ex-
press the DTR under control of the CD11c promoter, making
DCs susceptible to diphtheria toxin (DTx). As controls, irradiated
WT recipients, reconstituted with either WT BM (WT BM>>WT)
or BM isolated from mice deficient in the alpha chain of T cell re-
ceptor (TCRa/ BM>>WT), were used. After 6–8 weeks recov-
ery, the three groups were treated with 100 ng (5 ng/g body
weight) DTx and immunized with heat-inactivated SP in the
footpad 48 hr later. IgM titers were assessed by ELISA at day
10 post-immunization (Figures S3A–S3D). As expected, WT
BM>>WT and TCRa/ BM>>WT chimeric mice treated with
DTx responded with a robust IgM titer. By contrast, the IgM
response was severely diminished in CD11c-DTR BM>>WT chi-
meras when administered DTx. These results support the
requirement of DCs in the initiation of a T-independent humoral
immune response against SP, and they suggest that DCs may
participate in the transport of SP to the follicle.
To assess the contribution of sinus-lining macrophages in the
immune response against SP, clodronate liposomes (CLLs) were
used to deplete phagocytic macrophages. Earlier studies have
used this approach to eliminate sinus-lining macrophages in
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Figure 3. DCs and B Cells Collaborate in the Transport of SP to
the FDCs
Mice were injected with fluorescently labeled SP (red) in the footpad as
described earlier. Four different mouse strains were used: wild-type (WT),
complement C3 knockout (C3/), complement receptor 2 (CD21) knockout
bone marrow (BM) in mMT B cell-deficient recipients (CD21/ BM>>mMT),
and CD11c-dtr BM in WT recipients (CD11c-dtr BM>>WT) injected with DTx
48 hr prior to immunization. The FDC network was stained using 8C12 (green).
(A) Confocal micrographs of pLN 12 hr after immunization with SP. Line in-
dicates LN capsule and dotted line indicates follicle area. Bottom row: gray-
scale image of the SP channel is shown. Scale bars, 100 mm.
(B) Quantification of confocal images by Cell Profiler software. Only co-
localized signal was measured (****p < 0.0001, ***p < 0.001, and **p < 0.01; ns,
not significant; ANOVA with Tukey’s multiple comparisons test).
(C) Overview shows complement receptor (CR) nomenclature and their
respective cluster of differentiation (CD) numbers.skin-draining LNs without affecting LNDCs (Gonzalez et al.,
2010; Junt et al., 2007). Importantly, under the conditions used
in this study, CLLs did not deplete LNDCs but did deplete
CD11b+ macrophages (Figures S3F and S3H). Subsequently,
the CLL-treated group and controls (PBS only or empty clodro-
nate liposomes [ECLLs]) were immunized with SP, and their
humoral response was assayed by quantitating number of anti-
body-secreting cells (ASCs) in the pLN and serum IgM titers
determined by ELISA. Remarkably, the CLL treatment had a
negligible effect on the IgM or total Ig response relative to the
control groups, and it did not affect the number of ASCs in the
LN (Figures S3C–S3E). By contrast, a knockdown of SIGN-R1
with anti-SIGN-R1 (clone 22D1), as described by Kang et al.
(2003), diminished the number of ASCs in the LN (Figure S4).
Taken together, LNDCs, but not sinus-lining macrophages, are
required for an immune response against SP.DCs and B Cells Collaborate to Transport SP to FDCs
As discussed above, naive mature B cells take up C3-opsonized
ICs via CD21within the follicles and deliver them to FDCs (Heest-
ers et al., 2013, 2014; Phan et al., 2007, 2009). To examine
whether transport of C3d-opsonized SP is also dependent on
CD21 expression in B cells, BM chimeras were constructed in
which lethally irradiated mMT mice, which lack mature B cells,
were reconstituted with BM from CD21/ mice. Thus, in the
chimeric mice, the only source of mature B cells was from the
donor-derived CD21/ BM, whereas the FDCs were CD21 suf-
ficient. C3-deficient mice (C3/) and CD11c-DTR BM chimeric
mice (CD11c-DTR BM>>WT) were used as a negative control
and WT mice were used as a positive control. The four groups
of mice were injected in the hock with labeled SP. Visualization
and quantification of cryosections prepared from draining LNs
identified the deposition of SP on FDCs in the WT mice, but
not in the C3-deficient and CD11c-DTR BM>>WT control
mice, as expected. Strikingly, a significant reduction in antigen
deposition was observed on FDCs in pLNs of the CD21/
mMT BM chimeras (Figures 3A and 3B). Interestingly, the pheno-
type observed in the CD21/ mMT BM chimeras was not as se-
vere as in C3/ or CD11c-DTR BM>>WT mice, suggesting
other C3-dependent pathways (such as LNDCs)may be involved
in SP transport (Figures 3A and 3B).
Previous studies reported that deposition of C3-opsonized SP
on FDCs correlates with the B cell memory response (Kang et al.,
2006). To determine if DCs (CD11c+) can transport SP
directly to the FDCs, MP-IVM was used in combination with
the CD11c-eYFP reporter mice. Visualization of early events
following subcutaneous injection of labeled SP identified direct
transfer of SP from the LNDCs to the FDCs (Figure S3G; Movie
S1). However, given the limits of real-time imaging of the draining
LN, quantitation of the event was not possible by MP-IVM.
Therefore, an ex vivo FDC approach was established. Cd11c-
eYFP+ cells were sorted by fluorescence-activated cell sorting
(FACS) and loaded with complement-opsonized SP. Subse-
quently, the cells weremagnetically sortedwith anti-CD45 beads
to remove unbound SP and co-cultured with FDCs previously
isolated and plated on coverslips (Heesters et al., 2013) (Figures
4A and 4B). After washing, co-cultures were imaged and SP
binding to FDCs was quantified (Figures 4C and 4D). Results
show that DCs are capable of transfer of SP to FDCs.
Our combined results suggest a model in which both LNDCs
and B cells are necessary for the efficient binding and transport
of C3-opsonized SP to the FDCs. Although naive non-cognate B
cells provide the major pathway for transport of opsonized SP to
the FDCs, LNDCs are crucial in the initial binding of SP that
drains into the LN and subsequently either transports the bacte-
ria directly to the FDCs or transfers opsonized bacteria to naive B
cells in a CD21-dependent mechanism. In our model SP enters
the LN through the afferent lymphatics after passive drainage
from the injection site. Due to its thick glycan capsule, SP has
evaded complement so far and thus does not bind CR3/
CD11b on SCSMs. Cells in the medulla are capable of binding
SP through the SIGN-R1 receptor, which recruits C1q and acti-
vates the classical complement pathway. Macrophages can
then endocytose and digest the bacterium, while DCs can use
CR3 (or CR4/CD11c) to stabilize SP. Then there are multipleCell Reports 16, 3130–3137, September 20, 2016 3133
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Figure 4. DCs Can Transfer SP Directly to FDCs
(A) Schematic of experimental setup. LN single-cell suspension from CD11c-YFP mouse is made. YFP-positive DCs are sorted via FACS. Sorted DCs are
incubated with SP in the presence of complement components. Then DCs are sorted again using CD45magnetic beads to remove unbound SP. DCs carrying SP
are added to FDC cultures isolated 3 days prior.
(B) Sorted CD11c-YFP DC multiple carrying SP (CMTPX) on its surface is shown. Scale bar, 10 mm.
(C) FDC (blue) loaded with SP (CMTPX) and a DC (YFP) transferring SP is shown. Scale bar, 10 mm.
(D) Quantification of SP transferred to FDCs through DCs is shown (****p < 0.0001, Student’s t test).possible pathways: (1) opsonized SP can be released and bound
by B cells through CR2, which transports SP to the FDC; (2) the
DC can transfer the opsonized SP from SIGN-R1 or CR3 or CR4
to CR2 on a B cell, which transports SP to the FDC; or (3) the DC
can transport opsonized SP to the FDC by itself and transfer it to
CR1/CR2 on the FDC. The FDC then incorporates SP into a non-
degradative cycling endosomal compartment, periodically dis-
playing the antigen to cognate B cells in the GC reaction.
DISCUSSION
Early studies with SP reported that efficient clearance and host
protection to the encapsulated bacteria were dependent on
complement C3 and Ig (Brown et al., 2002; Griffioen et al.,
1991; Neufield and Rimpau, 1904; Ward and Enders, 1933).
Kang et al. (2004) made the unexpected observation that C3 op-
sonization of SP by LN macrophages was dependent on recog-
nition and binding ofmannan residues on the capsular surface by
the C-type lectin SIGN-RI. Moreover, they demonstrated that SP
deposition on FDCs within the follicles of draining LNs was C3
dependent and correlated with protective humoral immunity.
These elegant studies raised the general question of the under-
lying mechanism for transport of C3-opsonized SP from the
afferent lymphatics and delivery to the FDCs.
To address this important question, we developed a model in
which heat-inactivated SPwasfluorescently labeled and injected
into the hind limb (hock region) of WT and reporter mice. Labeled
SP was tracked both in real-time in CD11c-eYFP reporter mice3134 Cell Reports 16, 3130–3137, September 20, 2016usingMP-IVMandby confocal imaging of cryosections prepared
from the pLNs at varying time points. Strikingly, we found
that the bacteria drained passively via afferent lymphatics into
the medullary sinus, where they were rapidly taken up by MMs
and underlying LNDCs. Unexpectedly, we observed that
LNDCs migrated into the B cell follicles and directly transferred
labeled SP to FDCs. Delivery was impaired by selective elimina-
tion of LNDCs in CD11c-DTR BM chimeras with DTx ablation. A
limitation of this study is that DTx depletion also affects a small
subset of macrophages and neutrophils (Bennett and Clausen,
2007; Tittel et al., 2012). As a control, WT mice also were treated
with DTx. Further support for the importance of LNDCs came
from our results showing that humoral immunity to SP immuniza-
tion was significantly reduced following DTx ablation. Notably,
BM chimeras (CD21/ BM>>mMT), in which mature B cells
were deficient in the CD21 receptor, also showed a significant
reduction in the deposition of SP on FDCs following SP
immunization.
Based on the importance of both LNDCs and CD21+ B cells in
the delivery of SP to FDCs, we propose a mechanism by which
lymph-borne SP is bound by SIGN-R1+ LNDC and opsonized
with C3. CR3 and CR4 expressed on LNDCsmay stabilize reten-
tion of the C3-opsonized complexes. Subsequently, opsonized
SP is either delivered directly to FDCs or transferred to naive B
cells, which then deliver the complexes to FDCs in a CD21-
dependent pathway. These results do not rule out other path-
ways of delivery. For example, at later time points, it seems prob-
able that SP at the site of injection is phagocytosed by migratory
DCs that deliver the bacteria into the draining LNs. Although,
recent studies from our lab, using the UV-inactivated IAV (UV-
IAV) model, found that passive drainage of the antigen into the
LN was sufficient to support a protective IgG memory response
(Woodruff et al., 2014).
The findings that sinus-lining macrophages are not required
to support humoral immunity to SP and that SCSMs do not
appear to take up the bacteria were unexpected based on
earlier studies (Carrasco and Batista, 2007; Gaya et al., 2015;
Iannacone et al., 2010; Junt et al., 2007). One explanation for
the difference is that the nature and state of opsonization of
the particulate antigen dictates in part the pathway for uptake
and processing. SP is recognized by SIGN-R1, which is ex-
pressed by MMs and LNDCs, but not SCSMs, and earlier opso-
nization is unlikely due to SP’s thick glycocoat. In an earlier
study, we found that UV-inactive IAV, which also is decorated
with mannan oligosaccharides, was bound by both SCSMs
and MMs (as well as LNDCs). Notably in the IAV model,
SCSM binding was not essential in the humoral response,
whereas LNDC uptake was required (Gonzalez et al., 2010).
This is consistent with recent findings by Gaya et al. (2015)
where only live virus, bacteria, or Toll-like receptor (TLR) ligands
disrupted the SCSM layer, but UV-inactive IAV did not. Interest-
ingly, we did not observe any interaction with SCSMs, nor did
depletion with liposomes disrupt the immune response. Our
data emphasize that the mechanism of antigen capture in the
LN might be more complex than earlier reported. We hypothe-
size that differences between pathogens, mainly their ability to
evade complement fixation, dictate how they are processed in
the LN.
Transport of SP to FDCswas shown to be a collaborative effort
between DCs and B cells, which depended on C3 opsonization
most likely mediated by SIGN-R1 on DCs. We hypothesize that
SP is bound by SIGN-R1 and then opsonized with C3d, after
which CD11b or CD11c (CR3 or CR4) mediates stabilization of
the immune complex. Recent structural studies identified the
site on C3d that is bound by CR3 and found that it did not inter-
fere with the known site bound by CD21 (Bajic et al., 2013; van
den Elsen et al., 2002). The CR4-binding site does not seem to
interfere with CD21 (CR2) binding (Bajic et al., 2013). Thus, SP
opsonized with C3d can be recognized by both CR3/CR4 and
CD21 concurrently, and this could explain how the bacteria
can be transferred from LNDCs to CD21+ B cells or CD21+
FDCs. Although the impaired humoral response to SP seems
due to a defect in deposition on the FDCs, we do not exclude
a role for TFH cells, which might function as a regulatory agent.
It will be important in future studies to confirm the importance
of CR3/CR4 in LNDC transport of SP and gain a better under-
standing of the relative importance of direct transport of the bac-
teria by LNDCs versus handoff to naive B cells.
EXPERIMENTAL PROCEDURES
Mice
Mice were bred in house or were from Jackson ImmunoResearch Laboratories
or Charles River Laboratory. The following strains were used: WT (C57BL/6),
CD11c-eYFP, C3/, C1q/, CD21/, TCRa/, mMT, and CD11c-DTR
(Gack et al., 2007; Lindquist et al., 2004). All mice were on the C56BL/6 back-
ground. Mice were maintained in specific pathogen-free facilities at ImmuneDisease Institute, Dana Farber Cancer Institute, or Harvard Medical School.
All animal experiments were in accordance with protocols approved by the
Subcommittee on Research Animals Care at Harvard Medical School and
The Immune Disease Institute, and they were in accordance with guidelines
set by the NIH.
Bacterial Strains and Growth Conditions
SP strain D39 was grown in Todd Hewitt broth supplemented with yeast ex-
tracts and horse blood until log phase (OD650 = 1.5) (Restrepo et al., 2005).
SP was then labeled by incorporation of CMTPX dye and heat inactivated at
65C for 30 min.
Antibodies
The following antibodies were purchased from BioLegend: anti-B220 (RA3-
6B2), anti-CD11c (N418), and anti-CD11b (M1/70). CD169 (36.112 and
MOMA-1) was acquired from AbD Serotec. Anti-CD35 (8C12), anti-SIGN-R1
(22D1 and ERTR-9), anti-CD11b (M1/70), and anti-F4/80 (HB-198; American
Type Culture Collection) were produced in house and were purified by affinity
chromatography. Secondary antibodies, including streptavidin-Alexa Fluor
488 (S11223), streptavidin-Alexa Fluor 568 (S11226), streptavidin-Alexa Fluor
633 (S21375), and Alexa Fluor 633-conjugated anti-rat (A21094) were all from
Invitrogen. Purified antibodies were labeled with Alexa Fluor 488 (A10235),
Alexa Fluor 568 (A10238), Alexa Fluor 633 (A20170), or Pacific blue
(P30012), according to the manufacturer’s instructions (Invitrogen).
Mouse Pretreatment
For labeling of FDCs, mice received 5 mg 8C12 antibody intraperitoneally 24 hr
before MP-IVM. For labeling of SCSMs in vivo, 1 mg fluorescence-labeled
CD169 was injected into the footpad 3–5 hr before MP-IVM.
ELISA and Enzyme-Linked Immunospot Assay
Mice were immunized with 13 105 bacteria subcutaneously. At day 10, blood
was collected and serum was obtained. ELISAs were done as described (Fer-
nandez Gonzalez et al., 2008). For enzyme-linked immunospot assays, pLNs
and spleens were removed aseptically and disrupted by passage through
70-mmmesh, and ASCs were quantified as described (Barrington et al., 2006).
Flow Cytometry and Data Analysis
A FACSCanto II (BD Biosciences) was used for flow cytometry. Dead cells
were excluded by sytox blue (Invitrogen). Data were analyzed with FlowJo
software version 9 (Tree Star).
Statistical Analysis
Samples were analyzedwith two-tailed Student’s t test or two-way ANOVA fol-
lowed by Tukey corrections to correct for multiple comparisons; p < 0.05 be-
tween groups was considered significant. Statistical analysis was performed
using GraphPad Prism version 6. Data are presented as data points with lines
representing mean values ± SD or as bar graphs with mean ± SD.
Bacteria Injection
Anesthetized mice were injected with 1 3 105 heat-inactivated CMTPX-
labeled bacteria in the hock (in a volume of 10 ml). At various time points, drain-
ing and non-draining LNs were isolated for analysis of bacterial trafficking and
SP strain D39-specific immune responses.
Histology and Microscopy
Cryosections of LNs embedded in optimal cutting temperature compound
(TissueTek) were prepared, then sections were washed with Hank’s balanced
salt solution and incubated with anti-FcR (2.4G2) and 2% BSA before incuba-
tion with antibody as described (Roozendaal et al., 2009). Transmission EM of
LNs injected with SP was performed as described (Roozendaal et al., 2009).
MP-IVM was performed as described (Gonzalez et al., 2010). For all mouse
pretreatments, the hocks were injected with a volume of no more than 10 ml.
Data were analyzed by the open source Fiji and Cell profiler software
packages.Cell Reports 16, 3130–3137, September 20, 2016 3135
In Vivo Imaging
Mice were pretreated by intravenous injection with fluorescent anti-CR2 to la-
bel the FDCs in vivo. After 24 hr, fluorescent SP was injected subcutaneously
into the footpad. The pLNwas surgically exposed andMP-IVMwas performed
as described (Miller et al., 2002). Data were analyzed by the open source Fiji
software package.
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